In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
400 News Items found
MSK helped Roberto Romero’s immune system grow an army of T cells to fight melanoma using TIL therapy, which offers new hope against solid tumors.
How MSK Used TIL Therapy To Treat Melanoma in Roberto

Learn how MSK uses TIL therapy for melanoma — the first cell therapy approved by the FDA to treat a solid tumor.
AACR sign
At AACR, MSK Researchers Spotlight Health Disparities and Propose Solutions

Topics included more diverse representation in clinical trials, racial disparities in colorectal cancer, and ancestry testing to improve diagnoses.
Harini Veeraraghavan stands in front of a radiology display
How MSK Doctors Are Using AI To Improve Radiation Treatment

MSK researchers are leading the development of new artificial intelligence (AI) models to improve the targeting of radiation therapy — teaching computers to better isolate tumors and spare more of the surrounding healthy tissue.
Dr. Eileen O'Reilly seen with MSK nurse Tiffany Upshaw.
New KRAS Targeted Therapy Shows Promise Against Pancreatic Cancer

Learn how a new drug shows great promise for treating pancreatic by targeting the KRAS mutation, which fuels 90% of the disease.
Mamadou Diallo
Personal Perspective: Diversity and Inclusion at MSK

Learn about diversity and inclusion at Memorial Sloan Kettering, as people from across MSK share their insights and personal experiences.
Richard Nixon with Benno and Nancy Schmidt
Mission Possible? Revisiting the ‘War on Cancer’ 50 Years Later

In 1971, Richard Nixon launched a “war on cancer.” It’s still raging.
An illustration of CRISPR-Cas9
In the Lab
A Cut Above: MSK-Developed Software Makes CRISPR More Precise

A freely accessible software program provides researchers with an easy way to optimize a popular genome-editing tool.
MSK medical oncologist Luis Diaz, Jr.
In the Clinic
The Science Behind the FDA’s Approval of an Immunotherapy for Mismatch Repair–Deficient Cancers

A new paper from MSK physician-scientist Luis Diaz presents the evidence on which the FDA approved the immunotherapy drug pembrolizumab for cancers with a specific genetic abnormality.
Human metastatic melanoma cells in a lymph node. ENPP1, a protein involved in immune evasion, is shown in green.
Taking the STING Out of Cancer: Discovery about How Cancer Cells Evade Immune Defenses Inspires New Treatment Approach

The research identifies a protein called ENPP1 as a potential drug target in the treatment of advanced cancers with chromosome instability.
Mushrooms growing on a mossy log on the forest floor
Do Mushroom Supplements Boost Immunity Against Cancer?

Dr. Gary Deng of the Integrative Medicine Service helps separate the hype from the proven health benefits of mushroom supplements.